Hey guys!Welcome to another Mortal kombat video!Intos theory and speculation I will be talking about the revenant character ...

Hey guys!Welcome to another 'History Of' Mortal Kombat video!Now In todays breakdown and analysis I will be talking about the ...

was added to Mortal Kombat 11 as post-launch DLC. If you're not familiar with Mortal Kombat 1, it is, despite its name, the latest game in the Mortal Kombat series. Released in September 2023, the ...

A new trailer was released today for the Mortal Kombat 1 Pro Kompetition Season 2. The trailer is mostly meant to build hype for the competitive events, but developer NetherRealm Studios also used ...

Floyd's surprise addition to Mortal Kombat 1 as an old-school hidden opponent says a lot about how vital nostalgia has been ...

Crush your enemies and see them driven before you. Conan THE Barbarian joins Mortal Kombat for early access players on January 21. May Crom help us all. Character available with Khaos Reigns ...

Conan The Barbarian joins Mortal Kombat for early access players on January 21, 2025. May Crom help us all. Conan The Barbarian is available with the Khaos Reigns Expansion, Bundle, or Kollection.

Here’s how it works. You can use any of these Fatalities to decimate your rivals locally, or via Mortal Kombat 1 crossplay to expand your pool of opponents. If you picked up the extra pack of ...

Mortal Kombat 1 downloadable content character Conan the Barbarian will launch on January 21 for Kombat Pack 2 / “Khaos Reigns” expansion owners and January 28 for all users, publisher Warner ...

Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are ...